-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Mereo BioPharma Group plc quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2022 to Q1 2025.
- Mereo BioPharma Group plc Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$8.33M, a 4.23% decline year-over-year.
- Mereo BioPharma Group plc annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$32.8M, a 55.4% decline from 2023.
- Mereo BioPharma Group plc annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$21.1M, a 56.7% increase from 2022.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)